Selection of a trioxaquine as an antimalarial drug candidate

被引:122
作者
Cosledan, Frederic [1 ]
Fraisse, Laurent [2 ]
Pellet, Alain [2 ]
Guillou, Francois [3 ]
Mordmueller, Benjamin [4 ,5 ]
Kremsner, Peter G. [4 ,5 ]
Moreno, Alicia [6 ,7 ]
Mazier, Dominique [6 ,7 ,8 ]
Maffrand, Jean-Pierre [2 ]
Meunier, Bernard [1 ]
机构
[1] Palumed, F-31682 Labege, France
[2] Sanofi Aventis Rech, F-31036 Toulouse, France
[3] Sanofi Aventis Rech, F-34184 Montpellier, France
[4] Univ Tubingen, Dept Parasitol, D-72074 Tubingen, Germany
[5] Hop Albert Schweitzer, Med Res Unit, Lambarene, Gabon
[6] Univ Paris 06, Unite Mixte Rech 5511, F-75013 Paris, France
[7] INSERM, U511, F-75013 Paris, France
[8] CHU Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75013 Paris, France
关键词
curative drug; malaria; Plasmodium; heme; alkglation;
D O I
10.1073/pnas.0804338105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Trioxaquines are antimalarial agents based on hybrid structures with a dual mode of action. One of these molecules, PA1103/SAR116242, is highly active in vitro on several sensitive and resistant strains of Plasmodium falciparum at nanomolar concentrations (e.g., IC50 value = 10 nM with FcM29, a chloroquine-resistant strain) and also on multidrug-resistant strains obtained from fresh patient isolates in Gabon. This molecule is very efficient by oral route with a complete cure of mice infected with chloroquine-sensitive or chloroquine-resistant strains of Plasmodia at 26-32 mg/kg. This compound is also highly effective in humanized mice infected with P. falciparum. Combined with a good drug profile (preliminary absorption, metabolism, and safety parameters), these data were favorable for the selection of this particular trioxaquine for development as drug candidate among 120 other active hybrid molecules.
引用
收藏
页码:17579 / 17584
页数:6
相关论文
共 33 条
[1]   Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes [J].
Benoit-Vical, Francoise ;
Lelievre, Joel ;
Berry, Antoine ;
Deymier, Caroline ;
Dechy-Cabaret, Odile ;
Cazelles, Jerome ;
Loup, Christophe ;
Robert, Anne ;
Magnaval, Jean-Francois ;
Meunier, Bernard .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1463-1472
[2]   Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon:: implications for the validity of tests in vitro vs. in vivo [J].
Borrmann, S ;
Binder, RK ;
Adegnika, AA ;
Missinou, MA ;
Issifou, S ;
Ramharter, M ;
Wernsdorfer, WH ;
Kremsner, PG .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2002, 96 (06) :660-663
[3]   Alkylating capacity and reaction products of antimalarial trioxanes after activation by a heme model [J].
Cazelles, J ;
Robert, A ;
Meunier, B .
JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (03) :609-619
[4]  
Cosledan F., 2006, French Patent Application, Patent No. [FR06/05235, 0605235]
[5]   Synthesis and antimalarial activity of trioxaquine derivatives [J].
Dechy-Cabaret, O ;
Benoit-Vical, F ;
Loup, C ;
Robert, A ;
Gornitzka, H ;
Bonhoure, A ;
Vial, H ;
Magnaval, JF ;
Séguéla, JP ;
Meunier, B .
CHEMISTRY-A EUROPEAN JOURNAL, 2004, 10 (07) :1625-1636
[6]  
Dechy-Cabaret O, 2000, CHEMBIOCHEM, V1, P281, DOI 10.1002/1439-7633(20001117)1:4<281::AID-CBIC281>3.0.CO
[7]  
2-W
[8]   QUANTITATIVE ASSESSMENT OF ANTI-MALARIAL ACTIVITY INVITRO BY A SEMIAUTOMATED MICRODILUTION TECHNIQUE [J].
DESJARDINS, RE ;
CANFIELD, CJ ;
HAYNES, JD ;
CHULAY, JD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (06) :710-718
[9]   Artemisinins target the SERCA of Plasmodium falciparum [J].
Eckstein-Ludwig, U ;
Webb, RJ ;
van Goethem, IDA ;
East, JM ;
Lee, AG ;
Kimura, M ;
O'Neill, PM ;
Bray, PG ;
Ward, SA ;
Krishna, S .
NATURE, 2003, 424 (6951) :957-961
[10]   The antimalarial trioxaquine DU1301 alkylates heme in malaria-infected mice [J].
Garah, Fatima Bousejra-El ;
Claparols, Catherine ;
Benoit-Vical, Francoise ;
Meunier, Bernard ;
Robert, Anne .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (08) :2966-2969